Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

The Effect of Breast Cancer Resistance Protein and P-Glycoprotein on the Brain Penetration of Flavopiridol, Imatinib Mesylate (Gleevec), Prazosin, and 2-Methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic Acid (PF-407288) in Mice

Lin Zhou, Kari Schmidt, Frederick R. Nelson, Veronica Zelesky, Matthew D. Troutman and Bo Feng
Drug Metabolism and Disposition May 2009, 37 (5) 946-955; DOI: https://doi.org/10.1124/dmd.108.024489
Lin Zhou
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kari Schmidt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederick R. Nelson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veronica Zelesky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew D. Troutman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bo Feng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 37 no. 5 946-955
DOI 
https://doi.org/10.1124/dmd.108.024489
PubMed 
19225039

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received September 9, 2008
  • Accepted February 12, 2009
  • Published online April 17, 2009.

Article Versions

  • Earlier version (February 18, 2009 - 08:31).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Lin Zhou,
  2. Kari Schmidt,
  3. Frederick R. Nelson,
  4. Veronica Zelesky,
  5. Matthew D. Troutman and
  6. Bo Feng
  1. Department of Pharmaceutics, University of Washington, Seattle, Washington (L.Z.); and Department of Pharmacokinetics, Dynamics, and Drug Metabolism, Pfizer Global Research and Development, Groton, Connecticut (K.S., F.R.N., V.Z., M.D.T., B.F.)
  1. Address correspondence to:
    Dr. Bo Feng, Pfizer Inc., Eastern Point Road, MS 8118W-131, Groton, CT 06340. E-mail: bo.feng2{at}pfizer.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: February 2009 to December 2019

AbstractFullPdf
Feb 2009750116
Mar 200924091
Apr 2009681584
May 2009442464
Jun 2009232336
Jul 2009312444
Aug 2009252248
Sep 2009202036
Oct 2009201722
Nov 200928914
Dec 2009431212
Jan 2010861231
Feb 2010541318
Mar 201042819
Apr 201052812
May 2010342123
Jun 2010451720
Jul 2010492134
Aug 2010482833
Sep 2010252228
Oct 2010372326
Nov 2010322422
Dec 2010241719
Jan 2011182529
Feb 2011162920
Mar 2011452232
Apr 201123924
May 2011222637
Jun 2011241120
Jul 2011221414
Aug 2011251017
Sep 2011341425
Oct 2011231530
Nov 2011241521
Dec 201123816
Jan 2012221613
Feb 201230919
Mar 2012703231
Apr 2012494035
May 2012336341
Jun 2012304916
Jul 2012245031
Aug 2012283923
Sep 2012114430
Oct 2012431743
Nov 2012442737
Dec 2012442030
Jan 2013453822
Feb 2013423231
Mar 2013291933
Apr 2013403836
May 2013334034
Jun 2013171515
Jul 2013261823
Aug 2013201421
Sep 2013301113
Oct 2013301520
Nov 2013141724
Dec 2013111515
Jan 2014281623
Feb 20141577
Mar 2014152112
Apr 2014172016
May 2014202312
Jun 2014222216
Jul 201421149
Aug 2014142111
Sep 2014102720
Oct 2014231424
Nov 201428811
Dec 2014201713
Jan 2015141712
Feb 2015151920
Mar 2015171816
Apr 2015331713
May 20157159
Jun 201519194
Jul 2015282415
Aug 201514268
Sep 201521226
Oct 201517179
Nov 20151987
Dec 201518216
Jan 2016191516
Feb 2016975
Mar 2016192024
Apr 201614185
May 201614109
Jun 201615179
Jul 201610169
Aug 2016122010
Sep 201615108
Oct 2016142016
Nov 20169114
Dec 20164146
Jan 20172262
Feb 20170111
Mar 20177223
Apr 20173248
May 201753121
Jun 20173196
Jul 20173249
Aug 20171306
Sep 20173275
Oct 20174286
Nov 20177268
Dec 20174143
Jan 20181226
Feb 201831919
Mar 201812317
Apr 201802612
May 201802815
Jun 20180248
Jul 201803020
Aug 201802110
Sep 20180175
Oct 20180147
Nov 201803718
Dec 20181357
Jan 20192036
Feb 20191657
Mar 2019986
Apr 20191677
May 201913710
Jun 2019500
Jul 20192175
Aug 20191464
Sep 20191853
Oct 20191611
Nov 20194236
Dec 20191611

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 37 (5)
Drug Metabolism and Disposition
Vol. 37, Issue 5
1 May 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Effect of Breast Cancer Resistance Protein and P-Glycoprotein on the Brain Penetration of Flavopiridol, Imatinib Mesylate (Gleevec), Prazosin, and 2-Methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic Acid (PF-407288) in Mice
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
Citation Tools
Research ArticleArticle

The Effect of Breast Cancer Resistance Protein and P-Glycoprotein on the Brain Penetration of Flavopiridol, Imatinib Mesylate (Gleevec), Prazosin, and 2-Methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic Acid (PF-407288) in Mice

Lin Zhou, Kari Schmidt, Frederick R. Nelson, Veronica Zelesky, Matthew D. Troutman and Bo Feng
Drug Metabolism and Disposition May 1, 2009, 37 (5) 946-955; DOI: https://doi.org/10.1124/dmd.108.024489

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

The Effect of Breast Cancer Resistance Protein and P-Glycoprotein on the Brain Penetration of Flavopiridol, Imatinib Mesylate (Gleevec), Prazosin, and 2-Methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic Acid (PF-407288) in Mice

Lin Zhou, Kari Schmidt, Frederick R. Nelson, Veronica Zelesky, Matthew D. Troutman and Bo Feng
Drug Metabolism and Disposition May 1, 2009, 37 (5) 946-955; DOI: https://doi.org/10.1124/dmd.108.024489
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Abundant expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1 and xCT transporters in blood-arachnoid barrier of pig, and polarized localizations at CSF- and blood-facing plasma membranes
  • Pharmacokinetics of Organic Cation Transporter 1 (OCT1) Substrates in Oct1/2 Knockout Mice and Species Difference in Hepatic OCT1-mediated Uptake
  • Human Cytochrome P450 1A1 Adapts Active Site for Atypical Nonplanar Substrate
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics